Effects of Large Doses of Furosemide in End-Stage Chronic Renal Failure
作者:
P.J.C. Vereerstraeten,
F. Dupuis,
C. Toussaint,
期刊:
Nephron
(Karger Available online 1975)
卷期:
Volume 14,
issue 5
页码: 333-338
ISSN:1660-8151
年代: 1975
DOI:10.1159/000180464
出版商: S. Karger AG
关键词: Furosemide;Renal function;End-stage chronic renal failure;Regular dialysis treatment
数据来源: Karger
摘要:
Administered orally at 500 mg/day to patients in end-stage chronic renal failure treated by hemodialysis, furosemide significantly decreases the weight gain between dialyses and increases sodium excretion rate. This therapy remains without effect on blood pressure, creatinine clearance and urinary excretion of potassium and nitrogen. Devoid of any side-effects, at least during short periods, the treatment may contribute to achieve better control of sodium and water balance.
点击下载:
PDF
(645KB)
返 回